Flow Cytometry Market

Market Overview:

The global flow cytometry market size reached US$ 5.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 8.6 Billion by 2028, exhibiting a growth rate (CAGR) of 8.1% during 2023-2028.

Flow cytometry refers to a biophysical and laser-based analytical technology that is used in the analysis of the cells or micelles that are usually suspended in a fluid using a laser beam. This technique aids in subclassifying cell types and detecting residual levels of disease through probes to develop the best treatment plan for the patient. Fluorescent probes, such as bisoxonol, can bind to proteins present on the cell membrane to facilitate the identification of various stages of cell injuries or necrosis. This technique also aids in understanding the structure and composition of the cells for chromosome analysis, cancer diagnosis, protein expression and diagnosis of diseases and hematological malignancies. 

The increasing prevalence of chronic medical ailments, such as HIV-AIDS and cancer, is one of the key factors driving the growth of the market. The diagnosis of these diseases requires toxicity testing and an accurate, rapid and sensitive prognosis technique, which, in turn, is creating a positive outlook for the market growth. Furthermore, the widespread adoption of stem cell therapy is also enhancing the utilization of flow cytometry. Rising awareness regarding the benefits of this technique in immunophenotyping, cell sorting, cell proliferation assays and intracellular calcium flux is acting as another major growth-inducing factor. Additionally, several technological advancements, such as the integration of flow cytometry devices with artificial intelligence (AI) platforms, along with the advent of advanced methods, are also contributing to the market growth. Other factors, including improvements in the healthcare infrastructure, along with extensive research and development (R&D) activities in the field of biotechnology, are projected to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global flow cytometry market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product and service, technology, application and end-user.

Breakup by Product and Service:

• Instruments
• Reagents and Consumables
• Accessories
• Software
• Services
   

Breakup by Technology:

• Cell-Based Flow Cytometry
• Bead-Based Flow Cytometry
   

Breakup by Application:

• Oncology
• Drug Discovery
• Disease Diagnosis
• Stem Cell Therapy
• Organ Transplantation
• Hematology
• Others
   

Breakup by End-User:

• Hospitals and Clinics
• Academic and Research Institutes
• Pharmaceutical and Biotechnology Companies
• Others
   

Breakup by Region:

• North America
  • United States
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa
   

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies Inc., Apogee Flow Systems Ltd., BD (Becton, Dickinson and Company), Beckman Coulter Inc. (Danaher Corporation), Bio-RAD Laboratories Inc., Enzo Life Sciences Inc., Luminex Corporation, Merck KGaA, Sony Biotechnology Inc., Sysmex Partec GmbH, Thermo Fisher Scientific Inc., etc.

Report Coverage: